3Baraniskin A,Kuhnhenn J,Schlegel U. Identification of microR-NAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system[J].{H}Blood,2011.3140-3146.
4Jahnke K,Hummel M,Korfel A. Detection of subclinical system-ic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes[J].{H}Journal of Clinical Oncology,2006.4754-4757.
5Ferreri AJ,Blay JY,Reni M. Prognostic scoring system for pri-mary CNS lymphomas:the International Extranodal Lymphoma Study Group experience[J].{H}Journal of Clinical Oncology,2003.266-272.
6Abrey LE,Ben-Porat L,Panageas KS. Primary central nervous system lymphoma:the Memorial Sloan-Kettering Cancer Center prog-nostic model[J].{H}Journal of Clinical Oncology,2006.5711-5715.
7Shenkier TN,Blay JY,O′Neill BP. Primary CNS lymphoma of T-cell origin:a descriptive analysis from the international primary CNS lymphoma collaborative group[J].J Clin Oncol,2005.2233-2239.
8Levy O,Deangelis LM,Filippa DA. Bcl-6 predicts improved prognosis in primary central nervous system lymphoma[J].{H}CANCER,2008.151-156.
9Rubenstein JL,Fridlyand J,Shen A. Gene expression and angiot-ropism in primary CNS lymphoma[J].{H}Blood,2006.3716-3723.
10Hottinger AF,Iwamoto FM,Karimi S. YKL-40 and MMP-9 as se-rum markers for patients with primary central nervous system lympho-ma[J].{H}Annals of Neurology,2011.163-169.
